Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies.
Zhuoer XieAntoine N SalibaJithma AbeykoonUmair MajeedDaniel R AlmquistJulia E WiedmeierEvandro BezerraXavier Andrade-GonzalezAshley HickmanKarl SorensonSagar RakshitChristopher E WeeSri Harsha TellaAnuhya KommalapatiNadine AbdallahJoshua C PritchettMariza De AndradeDipesh UpretyAndrew BadleyRami ManochakianSikandar AilawadhiAlan H BryceJoleen M HubbardNaseema GangatCarrie A ThompsonThomas E WitzigRobert R McWilliamsKonstantinos LeventakosThorvardur R HalfdanarsonPublished in: JCO oncology practice (2021)
The COVID-19 positivity rate was low on the basis of RS. Comparing the hospital admission and mortality outcomes with the NRS cohort, there were no significant differences. The value of routine pre-emptive screening of asymptomatic patients with cancer for COVID-19 remains low.